Dec 20, 2022 / 12:00PM GMT
Rachel Curtis Gravesen - Curtis Consult - IR
Hello and welcome. Thanks very much for joining us for today's call where we'll be discussing Redx's full-year results for the year ended September 30, 2022. I'm Rachel Curtis Gravesen and in a moment, Redx's Chief Executive Officer, Lisa Anson; the Chief Financial Officer, Peter Collum; Chief Scientific Officer, Richard Armer; and Dr. Jane Robertson, the company's Chief Medical Officer, will present the progress which has been made during the year by the company.
After the presentations, there'll be a chance to ask questions of the presenters. And for that Q&A session, if you're on the phone, you'll be able to ask your question live and the operator will explain the procedure of exactly how to do that before the start of the session. If you're participating via the webcast, you can ask a written question at any time during the presentation by clicking the ask-a-question button which is at the top right-hand corner of the screen below the webcast player window.
Please move to the next slide. Importantly before we begin, I'd like to draw
Full Year 2022 Redx Pharma PLC Earnings Call Transcript
Dec 20, 2022
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers